ERBB2 and neoplasm: The Hoxb7/Her2 transgenic mice, compared to Her2 transgenic animals, showed a delayed tumor onset reflected in a decreased tumor multiplicity but, once the tumor was established, Hoxb7 promoted tumor progression leading to the formation of larger masses and to a higher index of pulmonary micro-metastasis.